A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.
Latest Information Update: 14 Nov 2023
At a glance
- Drugs MPH-220 (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; First in man
- Sponsors Motric Bio
- 06 Nov 2023 Status changed from planning to recruiting.
- 23 Oct 2020 New trial record